Published in Arch Intern Med on January 08, 2001
Antihypertensive Drug/Gene Interactions and CV Events | NCT00005332
Mutations, Hormone Therapy (HRT) and Venous Thromboembolism | NCT00005515
Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet (2010) 1.57
Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol (2016) 0.85
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet (2014) 0.83
Stroke risk factor profiles in African American women: an interim report from the African-American Antiplatelet Stroke Prevention Study. Stroke (2002) 0.83
Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong. Asia Pac Fam Med (2011) 0.80
Genetic loci for retinal arteriolar microcirculation. PLoS One (2013) 0.80
Diuretic treatment of hypertension. Diabetes Care (2011) 0.79
Short-term and long-term risk of incident ischemic stroke after transient ischemic attack. Stroke (2009) 0.78
Genome-wide association study of retinopathy in individuals without diabetes. PLoS One (2013) 0.78
The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention. Curr Treat Options Cardiovasc Med (2003) 0.77
Diuretics: again the first step in the treatment of most patients with hypertension. Curr Control Trials Cardiovasc Med (2001) 0.75
Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke. Pharmacoepidemiol Drug Saf (2015) 0.75
The role of thiazide diuretics in preventing ischemic stroke. Arch Intern Med (2001) 0.75
Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs. Arch Intern Med (2001) 0.75
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Validating administrative data in stroke research. Stroke (2002) 5.90
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. West J Med (1992) 4.62
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
JNC VI: timing is everything. Lancet (1997) 3.48
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med (1994) 3.33
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet (1996) 3.28
Venous thromboembolism among new users of different oral contraceptives. Lancet (1999) 3.25
Time to act on drug safety. JAMA (1998) 3.22
Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med (1997) 3.05
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol (1997) 3.02
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Natural statins and stroke risk. Circulation (1999) 2.55
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke (1996) 2.48
Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation (1998) 2.47
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Potential problems with random zero sphygmomanometer. Lancet (1990) 2.31
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ (1989) 2.27
The association between cholesterol and death from injury. Ann Intern Med (1994) 2.26
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation (2007) 2.18